SM
CORV

Sabby Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Sabby Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-273,010
Closed -$819K – 282
2017
Q1 		$819K Sell
273,010
-164,710
-38% -$486K 0.04% 142
2016
Q4 		$1.21M Sell
437,720
-46,785
-10% -$134K 0.07% 136
2016
Q3 		$1.52M Buy
+484,505
New +$1.77M 0.06% 151

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

Sabby Management's CORV Position: Q2 2017 in Review

Sabby Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2017, closing a stake of 273,010 shares — an estimated $819K sold.

Sabby Management first reported a position in CORV in Q3 2016 and held it in 3 quarters. The position peaked at $1.52M in Q3 2016. 27 funds tracked by Wall St. Rank hold CORV as of Q2 2017.

  • Sabby Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2017 after selling out during the quarter.
  • Sabby Management sold 273,010 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2017, an estimated $819K.
  • Sabby Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2016 and held it in 3 quarters.
  • Sabby Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $1.52M in Q3 2016.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.